Description

Annual recommendations on the use of influenza vaccine in Canada are developed by the NACI Influenza Working Group (IWG) for consideration by NACI. Recommendations are developed based on a review of a variety of issues, which can include: the burden of influenza illness and the target populations for vaccination; efficacy, effectiveness, immunogenicity, and safety of influenza vaccines; vaccine schedules; and other aspects of influenza immunization. In addition, PHAC has expanded the mandate of NACI to include the consideration of programmatic factors in developing their recommendations to facilitate timely decision-making for publicly funded vaccine programs at provincial and territorial levels. These programmatic factors include economics, ethics, equity, feasibility, and acceptability.

Resources

Name	Format	Description	Link
Canadian Immunization Guide Chapter on influenza and statement on seasonal influenza vaccine for 2021–2022	HTML		https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2021-2022.html
Canadian Immunization Guide Chapter on influenza and statement on seasonal influenza vaccine for 2021–2022	HTML		https://www.canada.ca/fr/sante-publique/services/publications/vaccins-immunisation/guide-canadien-immunisation-declaration-vaccination-antigrippale-2021-2022.html

Tags

Topics

Categories